It was noted that in clinical samples of breast cancer, ALDH+ accounted for 39.4% in samples of BLBC, and similar results were obtained in studies on breast cancer cell lines7, while lower expression was observed in intraductal carcinoma and luminal type with better prognosis8. This evidence concerns the gene LDHA and breast carcinoma.